HIV Vaccines: From Prevention to Cure
Agenda
Prevention Keynote: HIV Vaccine Development: How will we translate scientific opportunity into public health impact?
Prevention Keynote: HIV Vaccine Development: How will we translate scientific opportunity into public health impact?
Media
Human Monoclonal Antibodies for Pre-Exposure Prophylaxis (PrEP) of HIV-1 Infection
Progress in Advancing Vaccine Concepts to P5 Efficacy Trials
Defining Correlates of Protection against HIV/SIV
Ad26 Based Vaccines for HIV and Beyond
Building on Prevention: How prophylactic vaccine trials inform HIV cure
Targeting HIV Where it Hurts
Targeting HIV Where it Hurts
Media
Treatment Keynote: Barriers to a Cure and Therapy: What will a vaccine need to do to be a success?
Planning Committee
Image
Susan Buchbinder, MD
Director of HIV Prevention Research, SFDPH
Image
Steven Deeks, MD
Co-Director, Clinical Core
Image
Paul Volberding, MD (Emeritus)
Former Co-Director and Principal Investigator, UCSF-Gladstone CFAR
Image
Warner Greene, MD, PhD
Director, Gladstone Center for HIV Cure Research
Contacts
Image
César Cadabes
Community Engagement and Communications Program Analyst
Image
Lauren Sterling
Associate Director, UCSF-Bay Area CFAR